The fund aims to provide capital growth by investing in a diversified global portfolio of predominantly equities. The fund is actively managed, and is not constrained by any requirement to track indices or conform to investment fashion.
Name | % Net Assets |
---|---|
Science Group | 3.7% |
Runge,160,2.6,65,Novartis | 3.0% |
Wal-Mart | 2.2% |
Groupe Bruxelles Lambert | 2.2% |
Leucadia National | 1.6% |
Continental Building Products | 1.6% |
Castings | 1.6% |
ExxonMobil | 1.6% |
Microgen | 1.6% |
Balfour Beatty | 1.6% |
Key | % Net Assets |
---|---|
Science Group | 3.7% |
Runge,160,2.6,65,Novartis | 3.0% |
Wal-Mart | 2.2% |
Groupe Bruxelles Lambert | 2.2% |
Other | 88.9% |
Date | 20-Nov-2024 |
---|---|
NAV | 538.66p |
Currency | GBP |
Change | 538.66p |
% | n/a |
YTD change | 18.24p |
YTD % | 3.50% |
Fund Inception | n/a |
---|---|
Fund Manager | Alex Grispos |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research